HUYA''s $50M Buyback: A Strategic Pivot or a Signal of Chinese Tech''s New
On March 18, 2026, HUYA Inc., a leading Chinese game live-streaming platform,
Corporate News
Corporate strategy, M&A activity, and business development in the commerce sector.
Beyond the Abstract: How IDEAYA''s AACR 2026 Presence Signals a Shift in Precision
IDEAYA Biosciences'' announcement of three clinical-stage abstracts for
Beyond the IND: How IN026''s mRNA Designation Signals a New Era for Chronic
The FDA's investigational new drug (IND) designation for Innorna's IN026,
Beyond the Demo: How Infraeo & VIAVI''s 1.6T Validation at OFC 2026 Signals
The planned demonstration of 800G and 1.6T interconnect validation by Infraeo
Beyond the Headline: How Innorna''s IND Approval Signals a New Era for mRNA
The FDA's approval of Innorna's IND application for IN026, a potential mRNA
Beyond Gout: How Innorna''s mRNA IND Approval Signals a New Era for Chronic
Innorna's FDA IND approval for IN026, a potential first-in-class mRNA therapy